Review




Structured Review

Galectin Therapeutics galectin 9 ligand
Galectin 9 Ligand, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-9/lgals3/pm42274584-45-25-25
Average 86 stars, based on 1 article reviews
galectin 9 ligand - by Bioz Stars, 2026-09
86/100 stars

Images

Related Articles

Clinical Proteomics:

Article Title:
Article Snippet: B. Galectin-9 C. galectin-9 tubulin + - NT siRNA - + gal9 siRNA 183 1516 409 186 6207 1483 D. 0.0 0.2 0.4 0.6 0.8 1.0 **** NT siRNA gal9 siRNA no rm al is ed g al ec tin -9 le ve ls NT siRNA gal9 siRNA Supplementary figure 1.

Article Title: Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
Article Snippet: Following AHSCT, biomarker concentrations decreased from baseline to the 1-year follow-up, with a median (IQR) of 454 (357–553) vs. 408 (328–495) pg/mL ( P = 0.0002) for Galectin-9; 49 (38–79) vs. 45 (35 to 75) pg/mL ( P = 0.012) for GDF-15, and 100 (54–164) vs. 58 (43–92) ng/mL ( P < 0.0001) for YKL-40.

Article Title:
Article Snippet: Primer sequences Gene name Forward primer Reverse primer hIL12A CACAAAAGATAAAACCAGCA CTCTCTGGAATTTAGGCAAC hIL6 GACAGCCACTCACCTCTTCAGAACG ATCCATCTTTTTCAGCCATCTTTGG hIL10 TCAAGGCGCATGTGAACTCC GATGTCAAACTCACTCATGGCT hTNFα ATGAGCACTGAAAGCATGATCC GAGGGCTGATTAGAGAGAGGTC ACTB CTGGAACGGTGAAGGTGACA AAGGGACTTCCTGTAACAACGCA Supplementary Figure 1 % o f e ve nt s Galectin-9 A.

Article Title: Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
Article Snippet: Following AHSCT, the CSF concentrations of Gal-9 and YKL-40 decreased from baseline to the 1-year follow-up, with a median (IQR) of 454 (357–553) vs. 408 (328–495) pg/mL ( P = 0.0002) for Galectin-9; and 100 (54–164) vs. 58 (43–92) ng/mL ( P < 0.0001) for YKL-40.

Article Title: Impact of endocrine disrupting chemicals on macrophages at the maternal-fetal interface.
Article Snippet: and phagocytosis of apoptotic cells [6–9].. In early pregnancy 30–40% of decidual cells are leukocytes, with macrophages accounting for 20–30% of them, ranking as the second most abundant population after uNK cells (60–70%) [10, 11].. However, a recent study analyzed the number of immune cells in decidua of the early pregnancy by imaging mass cytometry (IMC) and showed that the number of macrophages was higher than uNK cells in all three trimesters of pregnancy [12].

Article Title: Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
Article Snippet: Galectin-9 and YKL-40 concentrations decreased further and were even lower at the 2-year follow-up; median (IQR) 408 (328–495) vs. 376 (289–478) pg/mL ( P = 0.0009) for Galectin-9; and 62 (37–96) vs. 56 (30–83) ng/mL ( P < 0.0001) for YKL-40.

Article Title: Effect of the TIM-3/Gal-9 signaling pathway on macrophage polarization in peri-implantitis
Article Snippet: Its ligand, galectin-9 (Gal-9) is expressed in the nucleus, cell surface, and cytoplasm, and is present in nearly all biological systems [ ].

Article Title: Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
Article Snippet: This study aimed to investigate whether three cerebrospinal fluid biomarkers of progressive MS: Galectin-9, GDF-15, and YKL-40, were affected by treatment intervention with AHSCT for RRMS.

Biomarker Discovery:

Article Title:
Article Snippet: B. Galectin-9 C. galectin-9 tubulin + - NT siRNA - + gal9 siRNA 183 1516 409 186 6207 1483 D. 0.0 0.2 0.4 0.6 0.8 1.0 **** NT siRNA gal9 siRNA no rm al is ed g al ec tin -9 le ve ls NT siRNA gal9 siRNA Supplementary figure 1.

Article Title: Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
Article Snippet: Following AHSCT, biomarker concentrations decreased from baseline to the 1-year follow-up, with a median (IQR) of 454 (357–553) vs. 408 (328–495) pg/mL ( P = 0.0002) for Galectin-9; 49 (38–79) vs. 45 (35 to 75) pg/mL ( P = 0.012) for GDF-15, and 100 (54–164) vs. 58 (43–92) ng/mL ( P < 0.0001) for YKL-40.

Article Title:
Article Snippet: Primer sequences Gene name Forward primer Reverse primer hIL12A CACAAAAGATAAAACCAGCA CTCTCTGGAATTTAGGCAAC hIL6 GACAGCCACTCACCTCTTCAGAACG ATCCATCTTTTTCAGCCATCTTTGG hIL10 TCAAGGCGCATGTGAACTCC GATGTCAAACTCACTCATGGCT hTNFα ATGAGCACTGAAAGCATGATCC GAGGGCTGATTAGAGAGAGGTC ACTB CTGGAACGGTGAAGGTGACA AAGGGACTTCCTGTAACAACGCA Supplementary Figure 1 % o f e ve nt s Galectin-9 A.

Article Title: Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
Article Snippet: Following AHSCT, the CSF concentrations of Gal-9 and YKL-40 decreased from baseline to the 1-year follow-up, with a median (IQR) of 454 (357–553) vs. 408 (328–495) pg/mL ( P = 0.0002) for Galectin-9; and 100 (54–164) vs. 58 (43–92) ng/mL ( P < 0.0001) for YKL-40.

Article Title: Impact of endocrine disrupting chemicals on macrophages at the maternal-fetal interface.
Article Snippet: and phagocytosis of apoptotic cells [6–9].. In early pregnancy 30–40% of decidual cells are leukocytes, with macrophages accounting for 20–30% of them, ranking as the second most abundant population after uNK cells (60–70%) [10, 11].. However, a recent study analyzed the number of immune cells in decidua of the early pregnancy by imaging mass cytometry (IMC) and showed that the number of macrophages was higher than uNK cells in all three trimesters of pregnancy [12].

Article Title: Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
Article Snippet: Galectin-9 and YKL-40 concentrations decreased further and were even lower at the 2-year follow-up; median (IQR) 408 (328–495) vs. 376 (289–478) pg/mL ( P = 0.0009) for Galectin-9; and 62 (37–96) vs. 56 (30–83) ng/mL ( P < 0.0001) for YKL-40.

Article Title: Effect of the TIM-3/Gal-9 signaling pathway on macrophage polarization in peri-implantitis
Article Snippet: Its ligand, galectin-9 (Gal-9) is expressed in the nucleus, cell surface, and cytoplasm, and is present in nearly all biological systems [ ].

Article Title: Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
Article Snippet: This study aimed to investigate whether three cerebrospinal fluid biomarkers of progressive MS: Galectin-9, GDF-15, and YKL-40, were affected by treatment intervention with AHSCT for RRMS.

Electrochemiluminescence:

Article Title:
Article Snippet: B. Galectin-9 C. galectin-9 tubulin + - NT siRNA - + gal9 siRNA 183 1516 409 186 6207 1483 D. 0.0 0.2 0.4 0.6 0.8 1.0 **** NT siRNA gal9 siRNA no rm al is ed g al ec tin -9 le ve ls NT siRNA gal9 siRNA Supplementary figure 1.

Article Title: Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
Article Snippet: Following AHSCT, biomarker concentrations decreased from baseline to the 1-year follow-up, with a median (IQR) of 454 (357–553) vs. 408 (328–495) pg/mL ( P = 0.0002) for Galectin-9; 49 (38–79) vs. 45 (35 to 75) pg/mL ( P = 0.012) for GDF-15, and 100 (54–164) vs. 58 (43–92) ng/mL ( P < 0.0001) for YKL-40.

Article Title:
Article Snippet: Primer sequences Gene name Forward primer Reverse primer hIL12A CACAAAAGATAAAACCAGCA CTCTCTGGAATTTAGGCAAC hIL6 GACAGCCACTCACCTCTTCAGAACG ATCCATCTTTTTCAGCCATCTTTGG hIL10 TCAAGGCGCATGTGAACTCC GATGTCAAACTCACTCATGGCT hTNFα ATGAGCACTGAAAGCATGATCC GAGGGCTGATTAGAGAGAGGTC ACTB CTGGAACGGTGAAGGTGACA AAGGGACTTCCTGTAACAACGCA Supplementary Figure 1 % o f e ve nt s Galectin-9 A.

Article Title: Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
Article Snippet: Following AHSCT, the CSF concentrations of Gal-9 and YKL-40 decreased from baseline to the 1-year follow-up, with a median (IQR) of 454 (357–553) vs. 408 (328–495) pg/mL ( P = 0.0002) for Galectin-9; and 100 (54–164) vs. 58 (43–92) ng/mL ( P < 0.0001) for YKL-40.

Article Title: Impact of endocrine disrupting chemicals on macrophages at the maternal-fetal interface.
Article Snippet: and phagocytosis of apoptotic cells [6–9].. In early pregnancy 30–40% of decidual cells are leukocytes, with macrophages accounting for 20–30% of them, ranking as the second most abundant population after uNK cells (60–70%) [10, 11].. However, a recent study analyzed the number of immune cells in decidua of the early pregnancy by imaging mass cytometry (IMC) and showed that the number of macrophages was higher than uNK cells in all three trimesters of pregnancy [12].

Article Title: Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
Article Snippet: Galectin-9 and YKL-40 concentrations decreased further and were even lower at the 2-year follow-up; median (IQR) 408 (328–495) vs. 376 (289–478) pg/mL ( P = 0.0009) for Galectin-9; and 62 (37–96) vs. 56 (30–83) ng/mL ( P < 0.0001) for YKL-40.

Article Title: Effect of the TIM-3/Gal-9 signaling pathway on macrophage polarization in peri-implantitis
Article Snippet: Its ligand, galectin-9 (Gal-9) is expressed in the nucleus, cell surface, and cytoplasm, and is present in nearly all biological systems [ ].

Article Title: Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
Article Snippet: This study aimed to investigate whether three cerebrospinal fluid biomarkers of progressive MS: Galectin-9, GDF-15, and YKL-40, were affected by treatment intervention with AHSCT for RRMS.

Multiplex Assay:

Article Title:
Article Snippet: B. Galectin-9 C. galectin-9 tubulin + - NT siRNA - + gal9 siRNA 183 1516 409 186 6207 1483 D. 0.0 0.2 0.4 0.6 0.8 1.0 **** NT siRNA gal9 siRNA no rm al is ed g al ec tin -9 le ve ls NT siRNA gal9 siRNA Supplementary figure 1.

Article Title: Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
Article Snippet: Following AHSCT, biomarker concentrations decreased from baseline to the 1-year follow-up, with a median (IQR) of 454 (357–553) vs. 408 (328–495) pg/mL ( P = 0.0002) for Galectin-9; 49 (38–79) vs. 45 (35 to 75) pg/mL ( P = 0.012) for GDF-15, and 100 (54–164) vs. 58 (43–92) ng/mL ( P < 0.0001) for YKL-40.

Article Title:
Article Snippet: Primer sequences Gene name Forward primer Reverse primer hIL12A CACAAAAGATAAAACCAGCA CTCTCTGGAATTTAGGCAAC hIL6 GACAGCCACTCACCTCTTCAGAACG ATCCATCTTTTTCAGCCATCTTTGG hIL10 TCAAGGCGCATGTGAACTCC GATGTCAAACTCACTCATGGCT hTNFα ATGAGCACTGAAAGCATGATCC GAGGGCTGATTAGAGAGAGGTC ACTB CTGGAACGGTGAAGGTGACA AAGGGACTTCCTGTAACAACGCA Supplementary Figure 1 % o f e ve nt s Galectin-9 A.

Article Title: Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
Article Snippet: Following AHSCT, the CSF concentrations of Gal-9 and YKL-40 decreased from baseline to the 1-year follow-up, with a median (IQR) of 454 (357–553) vs. 408 (328–495) pg/mL ( P = 0.0002) for Galectin-9; and 100 (54–164) vs. 58 (43–92) ng/mL ( P < 0.0001) for YKL-40.

Article Title: Impact of endocrine disrupting chemicals on macrophages at the maternal-fetal interface.
Article Snippet: and phagocytosis of apoptotic cells [6–9].. In early pregnancy 30–40% of decidual cells are leukocytes, with macrophages accounting for 20–30% of them, ranking as the second most abundant population after uNK cells (60–70%) [10, 11].. However, a recent study analyzed the number of immune cells in decidua of the early pregnancy by imaging mass cytometry (IMC) and showed that the number of macrophages was higher than uNK cells in all three trimesters of pregnancy [12].

Article Title: Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
Article Snippet: Galectin-9 and YKL-40 concentrations decreased further and were even lower at the 2-year follow-up; median (IQR) 408 (328–495) vs. 376 (289–478) pg/mL ( P = 0.0009) for Galectin-9; and 62 (37–96) vs. 56 (30–83) ng/mL ( P < 0.0001) for YKL-40.

Article Title: Effect of the TIM-3/Gal-9 signaling pathway on macrophage polarization in peri-implantitis
Article Snippet: Its ligand, galectin-9 (Gal-9) is expressed in the nucleus, cell surface, and cytoplasm, and is present in nearly all biological systems [ ].

Article Title: Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
Article Snippet: This study aimed to investigate whether three cerebrospinal fluid biomarkers of progressive MS: Galectin-9, GDF-15, and YKL-40, were affected by treatment intervention with AHSCT for RRMS.



Similar Products

96
Bioss galectin 9 polyclonal antibody
Galectin 9 Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-9/Galectin+9+Polyclonal+Antibody/custom%40bs-0604r%4042446273
Average 96 stars, based on 1 article reviews
galectin 9 polyclonal antibody - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

86
Galectin Therapeutics galectin 9 ligand
Galectin 9 Ligand, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-9/lgals3/pm42274584-45-25-25
Average 86 stars, based on 1 article reviews
galectin 9 ligand - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics transition gal 9 galectin 9 gsc glioblastoma stem cell
Transition Gal 9 Galectin 9 Gsc Glioblastoma Stem Cell, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-9/pm42274584-299-55-57
Average 86 stars, based on 1 article reviews
transition gal 9 galectin 9 gsc glioblastoma stem cell - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics effective immune response 67 galectin 9
Effective Immune Response 67 Galectin 9, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-9/pm42261224-207-37-40
Average 86 stars, based on 1 article reviews
effective immune response 67 galectin 9 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics galectin 9 expression
Galectin 9 Expression, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-9/pm42268362-704-3-3
Average 86 stars, based on 1 article reviews
galectin 9 expression - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics galectin 9 228 tim
Galectin 9 228 Tim, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-9/pm42264085-124-3-3
Average 86 stars, based on 1 article reviews
galectin 9 228 tim - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics galectin 9 encoding mrna levels
Galectin 9 Encoding Mrna Levels, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-9/lgals3/us12649794-697-5-5
Average 86 stars, based on 1 article reviews
galectin 9 encoding mrna levels - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics galectin 9 protein levels
Galectin 9 Protein Levels, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-9/lgals3/us12649794-692-0-0
Average 86 stars, based on 1 article reviews
galectin 9 protein levels - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

Image Search Results